Article

Favipiravir, umifenovir and camostat mesylate: a comparative study against SARS-CoV-2

2022-01-12

Abstract excerpt

Since the first cases the coronavirus disease caused by SARS-CoV-2 (COVID-19) reported in December 2019, worldwide continuous efforts have been placed both for the prevention and treatment of this infectious disease. As new variants of the virus emerge, the need for an effective antiviral treatment continues. The concept of preventing SARS-CoV-2 on both pre-entry and post-entry stages has not been much studied. Th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4013cdb0-a5eb-5130-8bf9-a9d7a6092920
DOI: 10.1101/2022.01.11.475889

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Favipiravir, umifenovir and camostat mesylate: a comparative study against SARS-CoV-2DOI 10.1101/2022.01.11.475889Read

Virtual screening FDA approved drugs against multiple targets of SARS‐CoV‐2Semantic proximity Read

Interaction of Drug Candidates with Various SARS-CoV‑2 Receptors: An in Silico Study to Combat COVID-19Semantic proximity Read

Nafamostat-interferon-alpha combination suppresses SARS-CoV-2 infection by targeting cooperatively host TMPRSS2 in vitro and in vivoSemantic proximity Read

Molecular Docking Reveals Ivermectin and Remdesivir as Potential Repurposed Drugs Against SARS-CoV-2Semantic proximity Read

Study of combining virtual screening and antiviral treatments of the Sars-CoV-2 (Covid-19)Semantic proximity Read

Anti-HIV and Anti-HCV drugs are the putative inhibitors of RNA-dependent-RNA polymerase activity of NSP12 of the SARS CoV-2 (COVID-19)Semantic proximity Read

Identification of novel small-molecule inhibitors of SARS-CoV-2 by chemical geneticsSemantic proximity Read

A Comprehensive Review of Drug Repurposing Strategies against Known Drug Targets of COVID-19Semantic proximity Read

Hepatitis C Virus Drugs Simeprevir And Grazoprevir Synergize with Remdesivir to Suppress SARS-CoV2 ReplicationSemantic proximity Read

Potential Inhibitors Targeting RNA-Dependent RNA Polymerase Activity (NSP12) of SARS-CoV-2Semantic proximity Read

Inhibitors of SARS-CoV‑2 Entry: Current and Future OpportunitiesSemantic proximity Read

A novel virtual screening procedure identifies Pralatrexate as inhibitor of SARS-CoV-2 RdRp and it reduces viral replication in vitroSemantic proximity Read